CLINICAL_TRIALS
withdrawal
· 2025-12-19
Clinical Trial Update: Use of Biodesign® Otologic Graft in Tympanoplasty [Phase 4]
Summary
A Phase 4 clinical trial evaluating the Biodesign Otologic Graft for tympanic membrane perforation was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Henry Ford Health System | Conditions: Tympanic Membrane Perforation | Phase 4 | Status: WITHDRAWN